| 216P The impact of pregnancy-associated breast cancer (PABC) according to immunohistochemical (IHC) subtype: A matched case-control study W Muñoz-Montaño, C De la Garza-Ramos, A Tabares, ... Annals of Oncology 31, S327, 2020 | | 2020 |
| 245P A multidisciplinary virtual intervention to address information needs of Mexican patients with breast cancer RL López-Bejarano, IR Olvera, A Mohar, PA Cabrera-Galeana, MB Pavón, ... Annals of Oncology 33, S235, 2022 | | 2022 |
| 767P Retrospective analysis of the impact of bevacizumab dose-intensity on the survival of platinum-resistant ovarian cancer patients JA Bahena, L Cetina-Pérez, D Gallardo-Rincón, P Cabrera-Galeana, ... Annals of Oncology 32, S750-S751, 2021 | | 2021 |
| A comprehensive health effects assessment of the use of sanitizers and disinfectants during COVID-19 pandemic: a global survey F Hashemi, L Hoepner, FS Hamidinejad, D Haluza, S Afrashteh, A Abbasi, ... Environmental Science and Pollution Research 30 (28), 72368-72388, 2023 | 10 | 2023 |
| A phase I, open-label, dose-escalation and cohort expansion study evaluating the safety and immune response to autologous dendritic cells transduced with AdGMCA9 in patients … I Faiena, N Zomorodian, B Comin-Anduix, A Sachadeva, A Bot, ... Journal of Clinical Oncology 36 (6_suppl), 653-653, 2018 | 1 | 2018 |
| A pilot trial of the combination of transgenic NY-ESO-1–reactive adoptive cellular therapy with dendritic cell vaccination with or without ipilimumab TS Nowicki, B Berent-Maoz, G Cheung-Lau, RR Huang, X Wang, J Tsoi, ... Clinical Cancer Research 25 (7), 2096-2108, 2019 | 86 | 2019 |
| Abstract CT008: A pilot trial of the combination of transgenic NY-ESO-1-reactive adoptive cellular therapy with dendritic cell vaccination with or without ipilimumab in … TS Nowicki, B Berent-Maoz, RR Huang, X Wang, G Cheung-Lau, ... Cancer Research 78 (13_Supplement), CT008-CT008, 2018 | | 2018 |
| Abstract P1-12-15: Quality of life, unmet needs and social support of patients with breast cancer during adjuvant endocrine therapy in Mexico L Gálvez-Hernández, I Páez-Gerardo, R Ramírez-Medina, V Neri-Flores, ... Cancer Research 79 (4_Supplement), P1-12-15-P1-12-15, 2019 | 2 | 2019 |
| Abstract P1-19-07: Real-world characteristics, treatment patterns, and overall survival in patients with metastatic breast cancer (mBC) and CNS metastases A Alvarado-Miranda, P Cabrera-Galeana, WR Muñoz-Montaño, ... Cancer Research 79 (4_Supplement), P1-19-07-P1-19-07, 2019 | 1 | 2019 |
| Abstract P2-07-13: OncoproMex®: An intelligent decision support system for Mexican breast cancer patients A Armengol-Alonso, FM Villalobos-Castaldi, P Cabrera-Galeana, ... Cancer Research 79 (4_Supplement), P2-07-13-P2-07-13, 2019 | | 2019 |
| Abstract P2-11-10: Effect of supplementation with eicosapentaenoic and docosahexaenoic omega-3 polyunsaturated fatty acid on the chemotoxicity in Mexican patients with locally … F DelaRosa-Oliva, E Ruiz-Garcia, E Gomez, C Arce-Salinas, ... Cancer Research 77 (4_Supplement), P2-11-10-P2-11-10, 2017 | 1 | 2017 |
| Abstract P2-13-05: Prevalence of trastuzumab-induced cardiotoxicity in a real-world setting O Calvillo-Argüelles, D Flores-Diaz, JP Gonzalez-Serrano, A López-Rojas, ... Cancer Research 79 (4_Supplement), P2-13-05-P2-13-05, 2019 | | 2019 |
| Abstract P2-13-08: Biopsychosocial changes since diagnosis and the time taking endocrine therapy in Mexican patients with breast cancer L Galvez-Hernandez, V Neri-Flores, I Paez-Gerardo, E Lopez-Muniz, ... Cancer Research 80 (4_Supplement), P2-13-08-P2-13-08, 2020 | | 2020 |
| Abstract P2-14-16: Optimal timing to initiate adjuvant chemotherapy in Mexican women with high risk luminal breast cancer P Cabrera-Galeana, L Mendoza-Oliva, W Munoz, C Villarreal-Garza, ... Cancer Research 80 (4_Supplement), P2-14-16-P2-14-16, 2020 | | 2020 |
| Abstract P3-07-10: Prognostic value of neutrophil-lymphocyte ratio in early breast cancer patients with ER+/Her2 negative and its association with 21 gen recurrence score I Maldonado-Noboa, P Cabrera-Galeana, C Arce-Salinas, ME Lara, ... Cancer Research 80 (4_Supplement), P3-07-10-P3-07-10, 2020 | | 2020 |
| Abstract P3-14-10: Shared decision-making approach in breast reconstruction in a developing country A Maciel-Miranda, LM Gutierrez-Zacarias, PA Cabrera-Galeana, ... Cancer Research 77 (4_Supplement), P3-14-10-P3-14-10, 2017 | | 2017 |
| Abstract P4-11-04: Palliative care and older women with advanced breast cancer in Mexico P Cabrera-Galeana, N Sánchez, E Verastegui, C Rodriguez, E Bargallo, ... Cancer Research 79 (4_Supplement), P4-11-04-P4-11-04, 2019 | 1 | 2019 |
| Abstract P5-08-13: Frequency of low bone mineral density in young women with breast cancer and associated factors F Mesa-Chavez, Y Chavarri-Guerra, S Ruiz-Cruz, P Cabrera-Galeana, ... Cancer Research 83 (5_Supplement), P5-08-13-P5-08-13, 2023 | | 2023 |
| Abstract P5-08-22: Impact of delay neoadjuvant chemotherapy on pathologic complete response in locally advanced breast cancer evidence of the real world in Mexico P Cabrera, W Muñoz, L Gutierrez, MT Ramirez, A Albarado, F Lara, ... Cancer Research 77 (4_Supplement), P5-08-22-P5-08-22, 2017 | | 2017 |
| Abstract P5-14-08: Not presented O Galindo-Vázquez, E Baragalló-Rocha, P Cabrera-Galeana, ... Cancer Research 79 (4_Supplement), P5-14-08-P5-14-08, 2019 | | 2019 |
Cynthia Villarreal-GarzaTecnológico de Monterrey在 tecsalud.mx 的电子邮件经过验证
